HUP0200832A2 - Babesia canis oltóanyag - Google Patents
Babesia canis oltóanyagInfo
- Publication number
- HUP0200832A2 HUP0200832A2 HU0200832A HUP0200832A HUP0200832A2 HU P0200832 A2 HUP0200832 A2 HU P0200832A2 HU 0200832 A HU0200832 A HU 0200832A HU P0200832 A HUP0200832 A HU P0200832A HU P0200832 A2 HUP0200832 A2 HU P0200832A2
- Authority
- HU
- Hungary
- Prior art keywords
- babesia canis
- proteins
- nucleic acid
- acid sequences
- vaccines
- Prior art date
Links
- 241000223846 Babesia canis Species 0.000 title abstract 8
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 150000007523 nucleic acids Chemical group 0.000 abstract 4
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A találmány tárgyát új Babesia canis-szal kapcsolatos fehérjéketkódoló nukleinsav-szekvenciák, és az ezeket a szekvenciákat tartalmazócDNS-fragmensek, rekombináns DNS-molekulák és élő rekombináns hordozókképezik. Ezenkívül a találmány tárgyát képezik gazdasejtek, amelyekilyen nukleinsav- szekvenciákat, cDNS-fragmenseket, rekombináns DNS-molekulákat és élő rekombináns hordozókat tartalmaznak. Továbbá atalálmány tárgyát képezik fehérjék, amelyeket ezen nukleinsav-szekvenciák kódolnak, oltóanyagok Babesia canis fertőzések elleniküzdelemre, amelyek ezen fehérjéket, vagy az ezen fehérjéket kódológenetikai anyagot tartalmazzák, és eljárások az oltóanyagokelőállítására. Egy másik megvalósítási mód szerint a találmány tárgyátképezik ezen Babesia canis-szal kapcsolatos fehérjék oltóanyagbantörténő alkalmazásra, és a Babesia canis-szal kapcsolatos fehérjékalkalmazása oltóanyag gyártásában. Végezetül a találmány tárgyátképezik diagnosztikai eszközök Babesia canis nukleinsav-szekvenciák,Babesia canis antigének detektálására, és Babesia canis antigenikusanyag elleni ellenanyagok detektálására. Ó
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200816 | 2001-03-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0200832D0 HU0200832D0 (hu) | 2002-05-29 |
| HUP0200832A2 true HUP0200832A2 (hu) | 2003-01-28 |
| HUP0200832A3 HUP0200832A3 (en) | 2008-05-28 |
Family
ID=8179969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200832A HUP0200832A3 (en) | 2001-03-06 | 2002-03-05 | Babesia canis vaccine |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US7090849B2 (hu) |
| JP (1) | JP4446647B2 (hu) |
| HU (1) | HUP0200832A3 (hu) |
| ZA (1) | ZA200201446B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4446647B2 (ja) * | 2001-03-06 | 2010-04-07 | インターベツト・インターナシヨナル・ベー・ベー | Ｂａｂｅｓｉａｃａｎｉｓワクチン |
| US20130287786A1 (en) * | 2010-12-29 | 2013-10-31 | Theodorus Petrus Maria Schetters | Canine babesiosis vaccine antigen |
| JP6767374B2 (ja) * | 2014-10-20 | 2020-10-14 | ジェン−プローブ・インコーポレーテッド | 赤血球溶解溶液 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA955551B (en) * | 1994-06-06 | 1996-04-01 | Akzo Nobel Nv | Babesia vaccine |
| EP0691131B1 (en) | 1994-06-06 | 1999-10-06 | Akzo Nobel N.V. | Babesia vaccine |
| US6045086A (en) | 1998-10-02 | 2000-04-04 | Hewlett-Packard Company | Method and apparatus for improved tape packing |
| EP1050541A1 (en) | 1999-04-29 | 2000-11-08 | Akzo Nobel N.V. | Babesia vaccine |
| JP4446647B2 (ja) | 2001-03-06 | 2010-04-07 | インターベツト・インターナシヨナル・ベー・ベー | Ｂａｂｅｓｉａｃａｎｉｓワクチン |
-
2002
- 2002-02-20 JP JP2002042621A patent/JP4446647B2/ja not_active Expired - Fee Related
- 2002-02-20 ZA ZA200201446A patent/ZA200201446B/xx unknown
- 2002-02-28 US US10/087,573 patent/US7090849B2/en not_active Expired - Fee Related
- 2002-03-05 HU HU0200832A patent/HUP0200832A3/hu unknown
-
2005
- 2005-10-11 US US11/249,112 patent/US7479284B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU0200832D0 (hu) | 2002-05-29 |
| JP2002360285A (ja) | 2002-12-17 |
| US7479284B2 (en) | 2009-01-20 |
| US7090849B2 (en) | 2006-08-15 |
| ZA200201446B (en) | 2002-09-02 |
| HUP0200832A3 (en) | 2008-05-28 |
| US20030165872A1 (en) | 2003-09-04 |
| US20080003223A1 (en) | 2008-01-03 |
| JP4446647B2 (ja) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303753A2 (hu) | Fúziós fehérjék immunogenitásának csökkentése | |
| MY150105A (en) | A novel surface exposed haemophilus influenzae protein (protein e; pe) | |
| PT1487485E (pt) | Adjuvantes de imidazoquinolina para vacinas de adn | |
| WO2001031019A3 (en) | Neisserial antigenic peptides | |
| BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
| HUP0105379A2 (hu) | Lawsonia intracellularis elleni oltóanyag | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| HUP0200832A2 (hu) | Babesia canis oltóanyag | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
| NO20081541L (no) | Ny sjo-lus vaksine | |
| CY1105947T1 (el) | Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
| JP2008500802A5 (hu) | ||
| WO2004024769A3 (en) | Ostertagia vaccine | |
| JP2007509837A (ja) | 多価エピトープキメラ遺伝子ワクチンの製法 | |
| WO2005049793A3 (en) | Methods and compositions for combinatorial approaches to cancer gene therapy | |
| DK1176192T3 (da) | Helicobacter felis-vaccine | |
| ATE315406T1 (de) | Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen | |
| WO2005053505A3 (es) | Uso del gen ncsag4 para el diagnóstico y prevención de la neosporosis, y como marcador para el análisis de la patogenia | |
| ATE450546T1 (de) | Impfstoffe mit ornithobakterium rhinotracheale- untereinheit | |
| AR040830A1 (es) | Vacuna para combatir la infeccion que produce la mastitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: INTERVET INTERNATIONAL B.V., NL Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |